As per the attachment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Rajnish Wellness Ltd reported a sharp decline in FY25 performance, with revenue from operations falling to Rs. 4,856.11 lakhs from Rs. 7,668.46 lakhs in FY24, a drop of about 37%. Profit after tax also fell steeply to Rs. 17.30 lakhs from Rs. 103.32 lakhs, an 83% decline. Q4 FY25 was particularly weak, posting a loss of Rs. 45.89 lakhs versus a profit of Rs. 28.27 lakhs in Q4 FY24, driven by revenue crashing to Rs. 577.41 lakhs from Rs. 2,698.31 lakhs. The auditor (Motilal & Associates LLP) issued an unmodified opinion with no qualifications. The board did not recommend any dividend for FY25. On the positive side, the company reduced its borrowings significantly, and operating cash flow improved from a negative Rs. 418.56 lakhs to a positive Rs. 53.08 lakhs.
Sharply lower revenue and profits, especially the Q4 loss, signal weakening business momentum and will likely be viewed negatively by shareholders, though the clean audit and improved cash flow position offer some comfort.